203 related articles for article (PubMed ID: 23017509)
1. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
J Urol; 2013 Mar; 189(3):935-9. PubMed ID: 23017509
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
[TBL] [Abstract][Full Text] [Related]
3. Economics and cost of care of stone disease.
Lotan Y
Adv Chronic Kidney Dis; 2009 Jan; 16(1):5-10. PubMed ID: 19095200
[TBL] [Abstract][Full Text] [Related]
4. [Urinary tract infections: Economical impact of water intake].
Bruyère F; Buendia-Jiménez I; Cosnefroy A; Lenoir-Wijnkoop I; Tack I; Molinier L; Daudon M; Nuijten MJ
Prog Urol; 2015 Sep; 25(10):590-7. PubMed ID: 26123650
[TBL] [Abstract][Full Text] [Related]
5. Economics of stone management.
Lotan Y; Pearle MS
Urol Clin North Am; 2007 Aug; 34(3):443-53. PubMed ID: 17678993
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
Tunis SL
Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
[TBL] [Abstract][Full Text] [Related]
7. Water intake and recurrent urinary tract infections prevention: economic impact analysis in seven countries.
Zemdegs J; Iroz A; Vecchio M; Roze S; Lotan Y
BMC Health Serv Res; 2023 Nov; 23(1):1197. PubMed ID: 37924070
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological trends in urolithiasis: impact on our health care systems.
Trinchieri A
Urol Res; 2006 Apr; 34(2):151-6. PubMed ID: 16440192
[TBL] [Abstract][Full Text] [Related]
9. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
10. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
Hamid R; Robertson WG; Woodhouse CR
BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
[TBL] [Abstract][Full Text] [Related]
11. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030.
Antonelli JA; Maalouf NM; Pearle MS; Lotan Y
Eur Urol; 2014 Oct; 66(4):724-9. PubMed ID: 25015037
[TBL] [Abstract][Full Text] [Related]
12. Fluid intake and epidemiology of urolithiasis.
Siener R; Hesse A
Eur J Clin Nutr; 2003 Dec; 57 Suppl 2():S47-51. PubMed ID: 14681713
[TBL] [Abstract][Full Text] [Related]
13. Role of Spiritual Sentiments in Improving the Compliance of Water Intake in Patients with Urolithiasis.
Ali L; Ali S; Hussain SA; Haider F; Ali S
J Relig Health; 2018 Feb; 57(1):26-32. PubMed ID: 27342410
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical and economic impact of nonadherence with osteoporosis medications.
Hiligsmann M; Rabenda V; Gathon HJ; Ethgen O; Reginster JY
Calcif Tissue Int; 2010 Mar; 86(3):202-10. PubMed ID: 20205345
[TBL] [Abstract][Full Text] [Related]
15. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
Palmer AJ; Tucker DM
Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
[TBL] [Abstract][Full Text] [Related]
16. Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents.
Turco MA; Kansal AR; Stern S; Amorosi SL; Underwood PL; Lissovoy GD; Dawkins KD
J Interv Cardiol; 2012 Aug; 25(4):353-63. PubMed ID: 22612261
[TBL] [Abstract][Full Text] [Related]
17. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL
Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339
[TBL] [Abstract][Full Text] [Related]
19. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing fluid intake behavior among kidney stone formers.
McCauley LR; Dyer AJ; Stern K; Hicks T; Nguyen MM
J Urol; 2012 Apr; 187(4):1282-6. PubMed ID: 22341296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
